Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

G7 agrees 1 billion COVID vaccine donation - communique

Published 06/13/2021, 04:23 AM
Updated 06/13/2021, 04:45 AM
© Reuters. FILE PHOTO: A G7 logo is seen on an information sign near the Carbis Bay hotel resort, where an in-person G7 summit of global leaders is due to take place in June, St Ives, Cornwall, southwest Britain May 24, 2021. Picture taken May 24, 2021. REUTERS/Toby

© Reuters. FILE PHOTO: A G7 logo is seen on an information sign near the Carbis Bay hotel resort, where an in-person G7 summit of global leaders is due to take place in June, St Ives, Cornwall, southwest Britain May 24, 2021. Picture taken May 24, 2021. REUTERS/Toby

CARBIS BAY, England (Reuters) - Group of Seven countries will provide 1 billion COVID-19 vaccine doses over the next year and work with the private sector, the G20 and other countries to increase the contribution over months to come, according to an almost finalised draft of the communique.

"The commitments since we last met in February 2021 including here in Carbis Bay provide for 1 billion doses over the next year," said the communique, seen by Reuters.

"We will work together with the private sector, the G20 and other countries to increase this contribution over the months to come," the communique said.

Two sources said the draft had been largely finalised by diplomats who worked late into Saturday night to agree most of the text, though they said parts of the draft could change over coming hours.

There were few disagreements over the communique, which is going through final drafting, though Japan pushed for a tougher line on China, a diplomatic source said.

The G7 said in the draft that the vaccine donations built on exports from domestic production with at least 700 million doses exported or to be exported this year, of which at least 50% have gone to non G7 countries.

The group added that it had "a commitment to continue exporting in significant proportions; and the promotion of voluntary licensing and not-for-profit global production, which has so far accounted for 95% of the COVAX supply," the communique said.

The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), aims to secure 2 billion vaccine doses for lower-income countries by the end of 2021.

"We reaffirm our support for all pillars of the ACT-A across treatments, tests and strengthening public health systems as well as vaccines," the communique said.

© Reuters. FILE PHOTO: A G7 logo is seen on an information sign near the Carbis Bay hotel resort, where an in-person G7 summit of global leaders is due to take place in June, St Ives, Cornwall, southwest Britain May 24, 2021. Picture taken May 24, 2021. REUTERS/Toby Melville

The ACT-Accelerator partnership was designed to accelerate the design, production and distribution of vaccines.

"We support discussions regarding the extension of the ACT-A mandate into 2022, noting the planned comprehensive review to optimise its effectiveness and accountability."

Latest comments

Agreed to $1B is way way different than, we will start to deliver $1B...
Just lincese the vaccines to poor countries so they can make their own cheaply.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.